Cleared Traditional

K895633 - MYOTRACE 10 BIOFEEDBACK DEVICE

K895633 is an FDA 510(k) clearance for MYOTRACE 10 BIOFEEDBACK DEVICE, manufactured by Noraxon USA, Inc.. The device is a Class 2 Neurology device with product code HCC cleared through the Traditional 510(k) pathway after a 206-day FDA review.

K895633 · Noraxon USA, Inc. · Neurology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Apr 1990
Decision
206d
Days
Class 2
Risk

K895633 is an FDA 510(k) clearance for the MYOTRACE 10 BIOFEEDBACK DEVICE. Classified as Device, Biofeedback (product code HCC), Class II - Special Controls.

Submitted by Noraxon USA, Inc. (Scottsdale, US). The FDA issued a Cleared decision on April 13, 1990 after a review of 206 days - an extended review cycle.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 882.5050 - the FDA neurology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Neurology review framework, consistent with the majority of Class II 510(k) submissions.

View all Noraxon USA, Inc. devices

FDA 510(k) Submission Details - K895633

510(k) Number K895633 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 19, 1989
Decision Date April 13, 1990
Days to Decision 206 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
58d slower than avg
Panel avg: 148d · This submission: 206d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

HCC Device Classification - Class 2, Special Controls

Product Code HCC Device, Biofeedback
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 882.5050
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Peers - HCC Device, Biofeedback

All 57
Devices cleared under the same product code (HCC) and FDA review panel - the closest regulatory comparables to K895633.
MYOTRAC+/S, MYODAC+/S
K913898 · Thought Technology , Ltd. · Mar 1992
FLEXCOMP DSP & PROCOMP
K903497 · Thought Technology , Ltd. · Feb 1991
M(3):MICRO MUSCLE MONITOR
K896409 · Thought Technology , Ltd. · Oct 1990
MYODAC2 BIOFEEDBACK DEVICE
K894840 · Thought Technology , Ltd. · Oct 1989
MYODAC
K883597 · Thought Technology , Ltd. · Nov 1988
MYOTRAC
K881416 · Thought Technology , Ltd. · Sep 1988